Skip to main content
OpenTrials

Clinical trial condition

Bronchitis, Chronic

Explore clinical trials studying Bronchitis, Chronic. Study availability and eligibility vary by location and protocol.

153 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Bronchitis, Chronic trial results

Completed

Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT01437540

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1493 Birmingham, Alabama, United States
  • Forest Investigative Site 1620 Birmingham, Alabama, United States
  • Forest Investigative Site 1127 Mobile, Alabama, United States
View all 137 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT01572792

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1827 Anniston, Alabama, United States
  • Forest Investigative Site 1920 Athens, Alabama, United States
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1493 Birmingham, Alabama, United States
View all 208 locations
View Trial Details
Completed

Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)

NCT01044459

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1127 Mobile, Alabama, United States
  • Forest Investigative Site 1475 Scottsdale, Arizona, United States
  • Forest Investigative Site 1338 Tempe, Arizona, United States
View all 113 locations
View Trial Details
Completed

Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01437397

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1827 Anniston, Alabama, United States
  • Forest Investigative Site 1920 Athens, Alabama, United States
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1493 Birmingham, Alabama, United States
View all 222 locations
View Trial Details
Completed

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 0909 Glendale, Arizona, United States
  • Forest Investigative Site 2050 Pheonix, Arizona, United States
  • Forest Investigative Site 2029 Rancho Mirage, California, United States
  • Forest Investigative Site 1084 Stockton, California, United States
View all 20 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)

NCT01045161

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1493 Birmingham, Alabama, United States
  • Forest Investigative Site 1419 Birmingham, Alabama, United States
  • Forest Investigative Site 1413 Muscle Shoals, Alabama, United States
  • Forest Investigative Site 1353 Pell City, Alabama, United States
View all 112 locations
View Trial Details

Related conditions